Related Experiment Video
Updated: Jan 30, 2026

Porcine As a Training Module for Head and Neck Microvascular Reconstruction
Published on: September 29, 2018
Targeting the LHX1-LDB1 Complex Restores STING-dependent Senescence Surveillance and Inhibits Head and Neck Cancer
Mingshu Long1, Yang Chen1,2, Ruixue Du1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China.
Abstract:
The senescence-associated secretory phenotype (SASP) exerts dual roles in tumor suppression and progression, yet how it is regulated in head and neck squamous cell carcinoma (HNSCC) remains unclear. Here, we identify LIM homeobox 1 (LHX1) as a key transcriptional suppressor of STING, whose downregulation enables evasion of SASP-mediated tumor surveillance. Notably, high LHX1 expression correlated with poor prognosis in HNSCC patients. Mechanistically, LHX1, in complex with LDB1, directly bound to the STING promoter to mediate transcriptional repression via the deposition of the repressive histone mark H3K9me3, thereby blocking SASP activation. Depletion of LHX1 restored STING-dependent SASP and impaired cancer stem cell self-renewal. Therapeutic disruption of the LHX1-LDB1 complex using engineered peptides re-activated STING signaling, induced SASP, and significantly suppressed tumor growth. In this study, we employed human and mouse-derived HNSCC cell lines, xenograft models, and clinical samples to assess the functional relevance of LHX1 in regulating SASP and tumor progression. Our findings reveal LHX1 as a master transcriptional repressor of STING-mediated senescence and highlight the therapeutic potential of targeting the LHX1-LDB1 axis to restore tumor-suppressive SASP in HNSCC.
Insights
LIM homeobox 1 (LHX1) suppresses STING and senescence-associated secretory phenotype (SASP) in head and neck cancer. Targeting LHX1 reactivates SASP, inhibiting tumor growth and improving prognosis for HNSCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The senescence-associated secretory phenotype (SASP) has complex roles in cancer, but its regulation in head and neck squamous cell carcinoma (HNSCC) is not fully understood.
- Understanding SASP regulation is crucial for developing novel cancer therapies.
Purpose of the Study:
- To investigate the role of LIM homeobox 1 (LHX1) in regulating the SASP in HNSCC.
- To explore the therapeutic potential of targeting the LHX1-LDB1 complex in HNSCC.
Main Methods:
- Utilized human and mouse HNSCC cell lines and xenograft models.
- Assessed the impact of LHX1 expression and depletion on STING signaling and SASP.
- Employed clinical HNSCC samples to correlate LHX1 expression with patient prognosis.
- Investigated therapeutic disruption of the LHX1-LDB1 complex using engineered peptides.
Main Results:
- Identified LHX1 as a transcriptional suppressor of STING, inhibiting SASP activation.
- Demonstrated that high LHX1 expression correlates with poor prognosis in HNSCC patients.
- Showed that LHX1 depletion restores STING-dependent SASP and impairs cancer stem cell self-renewal.
- Confirmed that therapeutic disruption of the LHX1-LDB1 complex re-activates STING, induces SASP, and suppresses tumor growth.
Conclusions:
- LHX1 acts as a master transcriptional repressor of STING-mediated senescence in HNSCC.
- Targeting the LHX1-LDB1 axis offers a promising therapeutic strategy to restore tumor-suppressive SASP in HNSCC.
More Related Videos
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Restorative Care
Targeted Cancer Therapies
There are several types of targeted therapies against...
Feedback Inhibition

